Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions.

Grosso, A; Douglas, I; Hingorani, A; Macallister, R; Smeeth, L; (2008) Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. British journal of clinical pharmacology, 66 (5). pp. 689-94. ISSN 0306-5251 DOI: https://doi.org/10.1111/j.1365-2125.2008.03273.x

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1111/j.1365-2125.2008.03273.x

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar